A detailed history of First Wilshire Securities Management Inc transactions in Siga Technologies Inc stock. As of the latest transaction made, First Wilshire Securities Management Inc holds 2,438,629 shares of SIGA stock, worth $15.2 Million. This represents 4.63% of its overall portfolio holdings.

Number of Shares
2,438,629
Previous 2,636,585 7.51%
Holding current value
$15.2 Million
Previous $20 Million 17.74%
% of portfolio
4.63%
Previous 6.12%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$6.74 - $11.97 $1.33 Million - $2.37 Million
-197,956 Reduced 7.51%
2,438,629 $16.5 Million
Q2 2024

Aug 13, 2024

SELL
$6.32 - $10.46 $111,674 - $184,828
-17,670 Reduced 0.67%
2,636,585 $20 Million
Q1 2024

May 15, 2024

BUY
$4.51 - $8.92 $1.32 Million - $2.61 Million
292,148 Added 12.37%
2,654,255 $22.7 Million
Q4 2023

Feb 12, 2024

BUY
$4.82 - $6.25 $1.43 Million - $1.86 Million
297,095 Added 14.39%
2,362,107 $13.2 Million
Q3 2023

Nov 14, 2023

BUY
$4.32 - $5.77 $2.72 Million - $3.64 Million
630,125 Added 43.91%
2,065,012 $10.8 Million
Q2 2023

Aug 14, 2023

BUY
$5.0 - $6.31 $2.25 Million - $2.84 Million
449,596 Added 45.63%
1,434,887 $7.25 Million
Q1 2023

May 15, 2023

BUY
$5.23 - $8.42 $4.54 Million - $7.31 Million
867,905 Added 739.36%
985,291 $5.67 Million
Q4 2022

Feb 14, 2023

SELL
$7.29 - $10.14 $8,682 - $12,076
-1,191 Reduced 1.0%
117,386 $864,000
Q3 2022

Nov 14, 2022

SELL
$10.02 - $26.15 $432,483 - $1.13 Million
-43,162 Reduced 26.69%
118,577 $1.22 Million
Q2 2022

Aug 15, 2022

BUY
$6.5 - $13.68 $1.05 Million - $2.21 Million
161,739 New
161,739 $1.87 Million

Others Institutions Holding SIGA

About SIGA TECHNOLOGIES INC


  • Ticker SIGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 73,024,096
  • Market Cap $456M
  • Description
  • SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...
More about SIGA
Track This Portfolio

Track First Wilshire Securities Management Inc Portfolio

Follow First Wilshire Securities Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Wilshire Securities Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on First Wilshire Securities Management Inc with notifications on news.